Name | Recombinant Human Kallikrein 14 Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 2626-SE |
Category | Protein |
Prices | $329.00 |
Sizes | 10 µg |
Species Reactivities | Human |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Gln19-Met248, with a C-terminal 10-His tag |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by its ability to cleave the fluorogenic peptide substrate Boc-VPR-AMC (Catalog # ES011 ). The specific activity is >3,000 pmol/min/µg, as measured under the described conditions. See Activity Assay Protocol on www.RnDSystems.com |
Endotoxin | <1.0 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | AAD50773 |
Gene | KLK14 |
Sequence | No results obtained: Gln19 predicted |
Supplier Page | Shop |
Fischer J, Koblyakova Y, Latendorf T, Wu Z, Meyer-Hoffert U. J Invest Dermatol. 2013 May;133(5):1170-7.
Fortugno P, Bresciani A, Paolini C, Pazzagli C, El Hachem M, D'Alessio M, Zambruno G. J Invest Dermatol. 2011 Nov;131(11):2223-32.
Meyer-Hoffert U, Wu Z, Kantyka T, Fischer J, Latendorf T, Hansmann B, Bartels J, He Y, Glaser R, Schroder JM. J Biol Chem. 2010 Oct 15;285(42):32174-81.
Sexton DJ, Chen T, Martik D, Kuzmic P, Kuang G, Chen J, Nixon AE, Zuraw BL, Forteza RM, Abraham WM, Wood CR. Biochem J. 2009 Aug 13;422(2):383-92.
Yoon H, Laxmikanthan G, Lee J, Blaber SI, Rodriguez A, Kogot JM, Scarisbrick IA, Blaber M. J Biol Chem. 2007 Nov 2;282(44):31852-64. Epub 2007 Sep 6.